Bausch & Lomb Corp

Ophthalmic Goods

BLCO Medical Devices & Diagnostics People in Medical Devices & Diagnostics SEC CIK 0001860742 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$6.16B
357,165,246 shares Covers every share class this company has on file.
Insiders on file
17
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$48.88M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
0.79%
insider-held value divided by market capitalisation

What Bausch & Lomb Corp reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$5.10B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$360.00M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
13,000
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at Bausch & Lomb Corp

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against Bausch & Lomb Corp.
Insider Reported role Shares Value Last action
Officers 4
A Robert D Bailey General Counsel 246,490 $4.45M A Grant or award Aug 5, 2026 position reported
Luc Bonnefoy Luc Bonnefoy President 100,001 $1.80M A Grant or award Aug 5, 2026 position reported
Frederick Munsch Chief Accounting Officer 98,313 $1.77M S Open-market sale Aug 10, 2026 position reported
Andrew J Stewart Andrew J Stewart President 90,649 $1.64M A Grant or award Aug 5, 2026 position reported
Officers who also sit on the board 4
Brent L. Saunders Brent L. Saunders CEO 981,275 $17.70M A Grant or award Aug 5, 2026 position reported
Sam Eldessouky Sam Eldessouky CFO 407,130 $7.34M A Grant or award Aug 5, 2026 position reported
Yehia Hashad EVP 180,041 $3.25M A Grant or award Aug 5, 2026 position reported
Steven H. Collis Executive Chairman 24,746 $446.4K A Grant or award May 26, 2026 position reported
Directors 9
Russel C. Robertson Russel C. Robertson Board Member 76,807 $1.39M A Grant or award May 26, 2026 position reported
John Paulson John Paulson Board Member 72,606 $1.31M A Grant or award May 26, 2026 position reported
Andrew C. von Eschenbach Board Member 70,814 $1.28M S Open-market sale Aug 7, 2026 position reported
Nathalie D Bernier Nathalie D Bernier Board Member 69,663 $1.26M A Grant or award May 26, 2026 position reported
Thomas W. Ross Sr. Board Member 69,391 $1.25M A Grant or award May 26, 2026 position reported
Brett Icahn Board Member 61,147 $1.10M A Grant or award May 27, 2025 position reported
Gaoxiang Hu Board Member 61,147 $1.10M A Grant or award May 27, 2025 position reported
Sarah B. Kavanagh Sarah B. Kavanagh Board Member 53,699 $968.7K A Grant or award May 26, 2026 position reported
Karen Ling Board Member 45,676 $824.0K A Grant or award May 26, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Bausch & Lomb Corp (BLCO) filed a Form 8-K/A under Item 5.02 (directors and officers) on Aug 12, 2026

Director or officer change filing

The company filed a current report that includes Item 5.02, the item used to report departures, elections or appointments of directors and certain officers, and related pay arrangements. We record only that this filing exists: we have not extracted who left, who joined or whose role changed. Open the filing to read it.

Form 8-K/A filed Aug 12, 2026, item 5.02. SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Frederick Munsch sold 52,900 Bausch & Lomb Corp (BLCO) shares for $887,662 on Aug 10, 2026

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Frederick Munsch sold 52,900 Bausch & Lomb Corp (BLCO) shares for $887,662 on Aug 10, 2026
Date Insider Transaction Shares Price Value Filing
Aug 10, 2026 Frederick Munsch S Open-market sale 52,900 held after: 45,831 $16.78 $887,662 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Bausch & Lomb Corp (BLCO) filed a Form 8-K under Item 5.02 (directors and officers) on Aug 6, 2026

Director or officer change filing

The company filed a current report that includes Item 5.02, the item used to report departures, elections or appointments of directors and certain officers, and related pay arrangements. We record only that this filing exists: we have not extracted who left, who joined or whose role changed. Open the filing to read it.

Form 8-K filed Aug 6, 2026, items 1.01, 5.02, 8.01, 9.01. SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

8 insiders bought Bausch & Lomb Corp (BLCO) shares worth $1,147,203 between Feb 19, 2026 and Mar 6, 2026

Cluster buying

8 different insiders made 8 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

8 insiders bought Bausch & Lomb Corp (BLCO) shares worth $1,147,203 between Feb 19, 2026 and Mar 6, 2026
Date Insider Transaction Shares Price Value Filing
Feb 19, 2026 Karen Ling P Open-market purchase 4,000 held after: 41,676 $17.74 $70,960 SEC filing ↗
Feb 20, 2026 Russel C. Robertson P Open-market purchase 4,400 held after: 72,407 $17.90 $78,760 SEC filing ↗
Feb 23, 2026 Steven H. Collis P Open-market purchase 15,000 held after: 20,255 $17.81 $267,150 SEC filing ↗
Feb 27, 2026 Andrew C. von Eschenbach P Open-market purchase 4,364 held after: 66,450 $18.31 $79,905 SEC filing ↗
Mar 3, 2026 Thomas W. Ross Sr. P Open-market purchase 4,500 held after: 64,891 $17.68 $79,560 SEC filing ↗
Mar 6, 2026 Brent L. Saunders P Open-market purchase 14,700 held after: 966,575 $17.14 $251,958 SEC filing ↗
Mar 6, 2026 Sam Eldessouky P Open-market purchase 4,000 held after: 403,130 $17.13 $68,520 SEC filing ↗
Mar 6, 2026 A Robert D Bailey P Open-market purchase 14,600 held after: 231,890 $17.15 $250,390 SEC filing ↗

Total of the rows above: $1,147,203, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Steven H. Collis bought 15,000 Bausch & Lomb Corp (BLCO) shares for $267,150 on Feb 23, 2026

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Steven H. Collis bought 15,000 Bausch & Lomb Corp (BLCO) shares for $267,150 on Feb 23, 2026
Date Insider Transaction Shares Price Value Filing
Feb 23, 2026 Steven H. Collis P Open-market purchase 15,000 held after: 20,255 $17.81 $267,150 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 152 rows we hold, 11 are open-market purchases (P) and 3 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for Bausch & Lomb Corp, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Aug 12, 2026 Barbara Trebbi A Grant or award 11,776 $0.00 $0 SEC filing ↗
Aug 12, 2026 Robert J Chersi A Grant or award 11,776 $0.00 $0 SEC filing ↗
Aug 10, 2026 Frederick Munsch S Open-market sale 52,900 $16.78 $887.7K SEC filing ↗
Aug 7, 2026 Andrew C. von Eschenbach S Open-market sale 6,059 $16.58 $100.5K SEC filing ↗
Aug 6, 2026 Andrew C. von Eschenbach S Open-market sale 12,500 $16.50 $206.3K SEC filing ↗
Aug 5, 2026 Andrew J Stewart A Grant or award 16,778 $0.00 $0 SEC filing ↗
Aug 5, 2026 Frederick Munsch A Grant or award 9,091 $0.00 $0 SEC filing ↗
Aug 5, 2026 Yehia Hashad A Grant or award 20,973 $0.00 $0 SEC filing ↗
Aug 5, 2026 Sam Eldessouky A Grant or award 50,335 $0.00 $0 SEC filing ↗
Aug 5, 2026 Luc Bonnefoy A Grant or award 16,778 $0.00 $0 SEC filing ↗
Aug 5, 2026 A Robert D Bailey A Grant or award 33,557 $0.00 $0 SEC filing ↗
Aug 5, 2026 Brent L. Saunders A Grant or award 281,879 $0.00 $0 SEC filing ↗
Aug 5, 2026 Brent L. Saunders F Shares withheld for taxes 4,231 $16.76 $70.9K SEC filing ↗
Jun 12, 2026 Luc Bonnefoy F Shares withheld for taxes 1,008 $15.08 $15.2K SEC filing ↗
May 26, 2026 Andrew C. von Eschenbach A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Thomas W. Ross Sr. A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Russel C. Robertson A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 John Paulson A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Karen Ling A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Sarah B. Kavanagh A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Steven H. Collis A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 26, 2026 Nathalie D Bernier A Grant or award 15,842 $15.78 $250.0K SEC filing ↗
May 22, 2026 Brent L. Saunders F Shares withheld for taxes 2,886 $15.92 $45.9K SEC filing ↗
May 5, 2026 Sam Eldessouky F Shares withheld for taxes 63,938 $16.00 $1.02M SEC filing ↗
May 5, 2026 Yehia Hashad F Shares withheld for taxes 13,664 $16.00 $218.6K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Subsidiaries — 83 legal entities

Subsidiaries of Bausch & Lomb Corp

83 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries Bausch & Lomb Corp names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
“Bausch Health” Limited Liability Company (aka “Bausch Health” LLC) Ukraine
AcuFocus Australia Pty. Ltd. Australia
AcuFocus Holdings, Inc. Delaware
AcuFocus, Inc. Delaware
Alden Optical Laboratories, Inc. New York
Audrey Enterprise, LLC Delaware
B L E P Holding GmbH Germany
B.L.J. Company Limited Japan
Bausch & Lomb (Australia) Pty Ltd Australia
Bausch & Lomb (Hong Kong) Limited Hong Kong
Bausch & Lomb (Malaysia) Sdn. Bhd. Malaysia
Bausch & Lomb (New Zealand) Limited New Zealand
Bausch & Lomb (Shanghai) Trading Co., Ltd. China
Bausch & Lomb (Singapore) Private Limited Singapore
Bausch & Lomb (South Africa) Pty Limited South Africa
Bausch & Lomb (Thailand) Limited Thailand
Bausch & Lomb Americas Inc. Delaware
Bausch & Lomb Argentina S.R.L. Argentina
Bausch & Lomb Australia Holdings Pty Ltd. Australia
Bausch & Lomb Financing LLC Delaware
Bausch & Lomb France France
Bausch & Lomb Gesellschaft m.b.H. Austria
Bausch & Lomb GmbH Germany
Bausch & Lomb Incorporated New York
Bausch & Lomb India Private Limited India
Bausch & Lomb Korea Co. Ltd. Korea
Bausch & Lomb México Holdings, S.A. de C.V. Mexico
Bausch & Lomb Nordic AB Sweden
Bausch & Lomb Pharma S.A. Belgium
Bausch & Lomb Philippines Inc. Philippines
Bausch & Lomb Poland Spółka z ograniczoną odpowiedzialnością (aka Bausch & Lomb Poland sp. z o.o.) Poland
Bausch & Lomb S.A. Spain
Bausch & Lomb Sağlik ve Optik Ürünleri Ticaret A.Ş. Turkey
Bausch & Lomb Swiss AG Switzerland
Bausch & Lomb Taiwan Limited Taiwan
Bausch & Lomb U.K. Limited United Kingdom
Bausch & Lomb-IOM S.P.A. Italy
Bausch + Lomb Ireland Limited Ireland
Bausch and Lomb Arabia Regional Headquarters Saudi Arabia
Bausch Foundation, LLC Delaware
Bausch Health Hellas Single-Member Pharmaceuticals Société Anonyme Greece
Bausch Health Korea Co., Ltd. Korea
Bausch Health Limited Liability Company Russian Federation
BAUSCH HEALTH LLC Belarus
Bausch Health LLP Kazakhstan
Bausch Health Peru, S.R.L. Peru
Bausch Health Romania S.R.L. Romania
Bausch Health Trading DWC - LLC United Arab Emirates
Bausch+Lomb Netherlands B.V. Netherlands
Beijing Bausch & Lomb Eyecare Company Ltd China
Bescon Co., Ltd. Korea
BL Indústria Ótica Ltda. Brazil
Cutting Edge France
Cutting Edge Surgical España Spain
Dr. Gerhard Mann chem.-pharm. Fabrik GmbH Germany
Dr. Mann Limited & Co. KG. Germany
Dr. Robert Winzer Pharma GmbH Germany
ELIOS Vision GmbH Germany
Elios Vision, Inc. Delaware
Grundstückverwaltungsgesellschaft Dr. G.M. chem.-pharm. Fabrik GmbH Germany
Kedalion Therapeutics, Inc. Delaware
Kestrel Ophthalmics Ltd. United Kingdom
Laboratoire Chauvin France
Paragon BioTeck, Inc. Nevada
PHARMASWISS društvo s ograničenom odgovornošću za trgovinu i usluge (aka PharmaSwiss d.o.o. Croatia) Croatia
PT Bausch Lomb Indonesia Indonesia
Servicio Integral De Esterilización, S.L.U. Spain
Servicio Integral Hospitalario, S.L.U. Spain
Shandong Bausch & Lomb Freda New Packaging Materials Co., Ltd. China
Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. China
Sino Concept Technology Limited Hong Kong
Soflens (Proprietary) Limited South Africa
Sterimedix Limited United Kingdom
Synergetics IP, Inc. Delaware
Synergetics, Inc. Missouri
TearLab Corporation (d/b/a Trukera Medical) Delaware
TearLab Research, Inc. (d/b/a Trukera Medical) Delaware
Technolas Perfect Vision GmbH Germany
Total Titanium, Inc. Illinois
Valeant Med Spółka z ograniczoną odpowiedzialnością Poland
Waicon Vision S.A. Argentina
Whitecap Biosciences LLC Delaware
Zhejiang Starview Medical Technology Co., Ltd. China
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from Bausch & Lomb Corp’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from Bausch & Lomb Corp’s own SEC filings multiplied by the closing price we hold for the same stock.

Logo: Bausch & Lomb Inc / Public domain , via Wikimedia Commons ↗ — used here to identify the company. Trademarks remain the property of their owner.